首页 › 基金 › Kalehua Capital Management LLC › MIST
Kalehua Capital Management LLC 对 MIST 的持仓历史
MILESTONE PHARMACEUTICALS IN · 医疗保健
Kalehua Capital Management LLC 在 Q3 2026 的 13F 申报中披露持有 MIST(MILESTONE PHARMACEUTICALS IN)1,651,258 股,市值约 US$1.4M,约占其申报组合的 1.08%,在其申报持仓中市值排名第 17 位。 Kalehua Capital Management LLC 最近 2 个申报季度中有 2 个季度披露了 MIST 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Kalehua Capital Management LLC 对 MIST 的持仓演变
Kalehua Capital Management LLC 于 Q2 2026 首次披露 MIST 持仓:1,269,237 股(约 US$1.7M)。 在 2 次申报中,Kalehua Capital Management LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,651,258 股、市值约 US$1.4M,环比增持 382,021 股。。 持仓曾出现大幅变动:Q3 2026 增持约 30% (随后一个季度股价下跌 40%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.27M | $1.70M | 新进 |
| Q3 2026 | 1.65M | $1.43M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MIST 与 13F 数据
MIST(MILESTONE PHARMACEUTICALS IN)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 MIST,申报仓位最大的包括:Propel Bio Management, LLC (US$8.2M), Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$2.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MIST 的基金
- Propel Bio Management, LLC 9.45M 股 · $8.18M · Q3 2026
- Pavaki Capital Management LLC 9.34M 股 · $8.08M · Q3 2026
- Simplify Asset Management Inc. 3.35M 股 · $2.90M · Q3 2026
- Lion Point Capital, LP 820.00K 股 · $1.10M · Q2 2026
更多关于 Kalehua Capital Management LLC
常见问题
How long has Kalehua Capital Management LLC held MIST?
Kalehua Capital Management LLC has disclosed MIST holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Kalehua Capital Management LLC's current position in MIST?
As of Q3 2026, Kalehua Capital Management LLC holds 1.65M shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $1.43M, representing 1.08% of its reported portfolio and ranking #17.
Has Kalehua Capital Management LLC been buying or selling MIST?
In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC increased its position in MIST.
Which other funds hold MIST?
Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Simplify Asset Management Inc., among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.